Tri-Mix

Injectable vial (Papaverine 30mg/mL + Phentolamine 1mg/mL + PGE1 10mcg/mL)Not available in all states

Marketing purposes only. Actual medications, if prescribed, are dispensed by a licensed pharmacy.

sexual health

Tri-MixTri-Mix

Intracavernosal injection combining three vasodilatory agents for erectile dysfunction refractory to oral PDE5 inhibitors. Water-based formulation injected directly into the corpus cavernosum.

Highest efficacy of any ED therapy (>90% response rate)

Effective when oral agents fail

Dose-titratable

Rapid onset (5 to 15 minutes)

No commitment · HSA/FSA eligibleNo commitment · HSA/FSA eligible

How it works

Mechanism of action

Papaverine inhibits PDE and relaxes smooth muscle; phentolamine blocks alpha-adrenergic vasoconstriction; PGE1 (alprostadil) activates adenylate cyclase increasing cAMP. Triple mechanism produces synergistic vasodilation in penile vasculature.

The baseline panel.

Every Marek client receives this baseline panel before a provider review. Your provider may add additional biomarkers based on your health history, symptoms, and goals, pulling from 1,000+ available markers. See more biomarkers →

Hormone Profile

12 markers

Sex hormones

  • Total TestosteroneLC/MS
  • Free TestosteroneEquilibrium Dialysis
  • Estradiol, Sensitive / UltrasensitiveLC/MS
  • Sex Hormone Binding Globulin (SHBG)
  • ProgesteroneLC/MSFemale panel
  • Prolactin
  • Luteinizing Hormone (LH)
  • Follicle-Stimulating Hormone (FSH)
  • hCG, Total, QuantitativeFemale panel, pre-menopause

Adrenals & neurosteroids

  • Cortisol
  • DHEA-S

Growth hormone / IGF-1

  • Insulin-Like Growth Factor I (IGF-1)

Thyroid Status

3 markers

Thyroid hormones

  • Thyroid Stimulating Hormone (TSH)
  • Free T4
  • Free T3

Heart Health

9 markers

Cardiovascular health

  • Total Cholesterol
  • HDL Cholesterol
  • LDL Cholesterol
  • LDL:HDL Ratio
  • VLDL Cholesterol
  • Triglycerides
  • Apolipoprotein-B (ApoB)
  • C-Reactive Protein, High Sensitivity (hsCRP)
  • Lipoprotein(a) (Lp(a))

Metabolism

3 markers

Insulin sensitivity

  • Blood Glucose
  • Fasting Insulin
  • HbA1c

Organ Function

26 markers

Liver & pancreas

  • AST
  • ALT
  • Bilirubin, Total
  • γ-Glutamyl Transferase (GGT)

Kidney function

  • BUN
  • Creatinine w/ eGFR

Comprehensive Metabolic Panel (CMP)

  • Glucose
  • Blood Urea Nitrogen (BUN)
  • Creatinine
  • eGFR
  • BUN/Creatinine Ratio
  • Sodium
  • Potassium
  • Chloride
  • Carbon Dioxide, Total
  • Calcium
  • Protein, Total
  • Albumin
  • Globulin, Total
  • Albumin/Globulin (A/G) Ratio
  • Alkaline Phosphatase (ALP)
  • AST
  • ALT

Prostate health

  • Prostate-Specific Antigen (PSA)Male panel
  • Free PSAMale panel
  • % Free PSAMale panel

Nutrient Status

31 markers

Vitamins & minerals

  • Vitamin D, 25-OHD (25-Hydroxy)
  • Magnesium, RBC

Iron status

  • Iron
  • Iron Saturation
  • TIBC
  • UIBC
  • Ferritin

Complete Blood Count (CBC)

  • White Blood Count (WBC)
  • Red Blood Count (RBC)
  • Hemoglobin (Hgb)
  • Hematocrit (HCT)
  • MCV
  • MCH
  • MCHC
  • Red Cell Distribution Width (RDW)
  • Platelets
  • Neutrophils
  • Neutrophils (Absolute)
  • Lymphocytes
  • Lymphocytes (Absolute)
  • Neutrophil/Lymphocyte Ratio
  • Monocytes
  • Monocytes (Absolute)
  • Eosinophils
  • Eosinophils (Absolute)
  • Basophils
  • Basophils (Absolute)
  • Immature Cells
  • Immature Granulocytes
  • Immature Granulocytes (Absolute)
  • NRBC, w/ Reflex for Immature Cells

Clinical evidence

The research behind Tri-Mix.

Tri-Mix Intracavernosal Injection for ED

Journal of Urology (1996)

Triple-agent combination achieved >90% erection adequate for intercourse with lower individual drug doses reducing side effects vs monotherapy.

Safety profile

Monitoring & safety information.

Commonly reported side effects

  • Penile pain at injection site
  • Bruising
  • Penile fibrosis (with repeated use)
  • Dizziness

Less common but serious risks

  • Priapism (erection >4 hours, medical emergency)
  • Penile fibrosis/Peyronie's disease
  • Hypotension

Generally not appropriate for

  • Sickle cell disease
  • Concurrent anticoagulation (relative)
  • Penile anatomical deformity
  • History of priapism

Typical monitoring

  • Response assessment and dose titration
  • Penile exam for fibrosis
  • Blood pressure

FAQ

Quick answers.

Compounded intracavernosal injection combining three vasodilatory agents for erectile dysfunction refractory to oral PDE5 inhibitors. Water-based formulation injected directly into the corpus cavernosum.
Highest efficacy of any ED therapy (>90% response rate). Effective when oral agents fail. Dose-titratable. Rapid onset (5 to 15 minutes).
Common side effects include: penile pain at injection site, bruising, penile fibrosis (with repeated use), dizziness. Most side effects are dose-dependent and may resolve with continued use or dose adjustment.
View all FAQs
See all FAQs

Compounded intracavernosal injection combining three vasodilatory agents for erectile dysfunction refractory to oral PDE5 inhibitors. Water-based formulation injected directly into the corpus cavernosum.

Treatments are dependent on licensed clinical prescription. Client costs vary based on individual labs and panel in treatments and services.